Viewing nowSitdium 50 mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

MFDS item code 202101984 · Approved 2021.03.03 · Insurance code 642707080
Improvement of glycemic control in type 2 diabetes mellitus
This medication is a treatment used to help control blood glucose levels in patients with type 2 diabetes, in conjunction with diet and exercise. It can be administered as monotherapy for patients starting treatment for the first time. If blood glucose control is insufficient after trying other diabetes medications, it is administered in combination with metformin. Furthermore, it is used in addition to other treatments when blood glucose control is difficult or insufficient after various combination therapies, including sulfonylurea, metformin, thiazolidinedione, or insulin monotherapy. This flexibility allows for its use in diverse situations to assist in blood glucose control for patients with type 2 diabetes.
Administer 100 mg once daily as monotherapy or combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dose adjustment is required according to renal function, assessment of renal function is recommended before and periodically during treatment with this medicine. 1. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.
This medication may rarely cause a severe allergic reaction, thus if symptoms such as skin rash, difficulty breathing, or swelling of the face or throat occur, you should stop taking it immediately and consult a doctor. This drug can cause a serious inflammation of the pancreas known as pancreatitis, so if symptoms such as abdominal pain, nausea, vomiting, or fever occur while taking this medication, you must stop taking it and seek medical advice. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, nor in patients allergic to this medication or its ingredients. Patients with impaired renal function may experience delayed excretion of this medication, and it is important to adjust the dosage under a physician's guidance and to regularly assess renal function. In clinical trials, side effects such as upper respiratory infections resembling colds, headaches, pharyngitis, and diarrhea were mostly reported, and the risk of hypoglycemia may increase when taken with insulin or sulfonylurea. Hypoglycemia symptoms may occur when this medication is used in combination with insulin or sulfonylurea, so it is important to monitor blood glucose levels frequently and adjust the dosage of these medications as necessary. If severe joint pain or blistering of the skin occurs during treatment, you should inform your physician immediately and stop taking the medication. The use of this drug is not recommended for pregnant or breastfeeding women, and its safety and efficacy have not been established in children and adolescents under 18 years of age. In cases of overdose, general emergency treatment should be conducted, and some of the drug can be removed through hemodialysis, so proper measures should be taken under the guidance of healthcare professionals. This medication generally has few drug interactions, but caution is needed when taking specific medications, so it is essential to inform healthcare providers of all medications being taken.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a sealed container to prevent exposure to air or moisture. It is advisable to maintain the storage temperature between 1 degree and 30 degrees Celsius.
A round, biconvex film-coated tablet in a light apricot color.
28 tablets/box [14 tablets/PTP × 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.